marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Soleno Therapeutics Income Statement 2011-2024 | SLNO
Annual Income Statement Soleno Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
17.4 M | 1.89 M | 156 M | 110 M | 36.1 M | 15.6 M | 13.1 M | 12.6 M | 1.69 M | - | - | - |
Shares |
8.4 M | 5.32 M | 79.6 M | 34.1 M | 21 M | 8.98 M | 3.1 M | 1.89 M | 254 K | - | - | - |
Historical Prices |
2.07 | 0.355 | 1.96 | 3.46 | 1.77 | 1.77 | 4.25 | 6.7 | 6.65 | - | - | - |
Net Income |
-24.1 M | -30.9 M | -24.6 M | -30.8 M | -13.3 M | -15.7 M | -12.1 M | -15.9 M | -13.9 M | -3.71 M | -6.48 M | - |
Revenue |
- | - | - | - | - | - | 1.45 M | 388 K | - | 3 M | - | - |
Cost of Revenue |
- | - | - | - | - | - | 1.51 M | 353 K | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | -58.5 K | 34.9 K | - | 3 M | - | - |
Operating Income |
-24.4 M | -31.5 M | -36.3 M | -23.5 M | -14.3 M | -12.2 M | -8.32 M | -12.2 M | -5.16 M | -847 K | - | - |
Interest Expense |
300 K | 110 K | 13 K | 154 K | 104 K | -590 K | 1.59 M | - | 4.13 M | 2.86 M | - | - |
EBITDA |
-22.4 M | -29.6 M | -30 M | -21.2 M | -11.8 M | -8.07 M | -13.5 M | -12.1 M | -5.13 M | -805 K | -3.57 M | - |
Operating Expenses |
24.4 M | 31.5 M | 31.9 M | 23.2 M | 13.7 M | 9.68 M | 13.6 M | 12.2 M | 5.16 M | 3.85 M | - | - |
General and Administrative Expenses |
9.84 M | 10.8 M | 8.76 M | 6.93 M | 6.56 M | 6.58 M | 6.74 M | 6.14 M | 2.67 M | 1.47 M | 1.13 M | - |
All numbers in USD currency
Quarterly Income Statement Soleno Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
41.9 M | 38.6 M | 36.2 M | 31.7 M | 11.4 M | 10.4 M | 9.45 M | 8.16 M | 8.09 M | 9.34 M | 5.33 M | 5.32 M | 5.32 M | 79.7 M | 79.7 M | 79.6 M | 79.6 M | 46.2 M | 44.7 M | 44.7 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 21.4 M | 20.3 M | 19.5 M | 19.2 M | 9.67 M | 9.52 M | 5.09 M | 3.36 M | 3.15 M | 15.5 M | 14.8 B | 14 M | 10 M | 7.52 M | 6.97 M | 6.77 M | 536 K | 536 K | 536 K | 536 K | 536 K | - | - | - | - | - | - | - | - | - | - |
Net Income |
-76.6 M | -21.9 M | -21.4 M | - | -10.9 M | -8.48 M | -8.36 M | - | -6.13 M | -6.72 M | -5.72 M | - | -8.14 M | -11 M | -8.95 M | - | -8.54 M | -7.38 M | -5.86 M | - | 889 K | -10 M | -7.03 M | - | -2.74 M | -7.06 M | -3.8 M | - | -3.79 M | -3.97 M | -2.89 M | - | -2.75 M | -3.51 M | -3.19 M | - | -3.29 M | 1.88 M | -11.7 M | - | -13.2 M | -13.2 M | -13.2 M | - | -1.59 M | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -478 K | -355 K | -190 K | - | - | - | - | - | - | 1 K | 265 K | - | 329 K | 2 K | 447 K | - | 247 K | 97 K | 22 K | - | - | - | - | - | 3 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42 K | 209 K | - | 399 K | 51 K | 461 K | - | 56 K | 22 K | 18 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -41 K | 56 K | - | -70 K | -49 K | -14 K | - | 191 K | 75 K | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-80.2 M | -24.9 M | -23.5 M | - | -10.4 M | -8.62 M | -8.47 M | - | -6.24 M | -6.78 M | -5.77 M | - | -8.29 M | -11.1 M | -9.16 M | - | -7.86 M | -11.2 M | -9.28 M | - | -6.13 M | -5.62 M | -4.98 M | - | -3.88 M | -3.41 M | -3.48 M | - | -2.63 M | -2.97 M | -1.37 M | - | -1.97 M | -2.3 M | -4.26 M | - | -3.18 M | -3.04 M | -2.43 M | - | -1.32 M | -1.31 M | -684 K | - | -993 K | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | 147 K | 113 K | - | 101 K | 52 K | 22 K | - | 34 K | 41 K | 1 K | - | 1 K | 1 K | 11 K | - | 29 K | 47 K | 57 K | - | 26 K | 30 K | 19 K | - | 3 K | -88 K | -672 K | - | - | - | - | - | - | - | 1 K | - | 752 K | 670 K | 388 K | - | 571 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -23 M | - | - | - | -7.98 M | - | -4.76 M | -5.8 M | -5.28 M | - | -6.82 M | -10.1 M | -8.67 M | - | -6.39 M | -10.2 M | -8.79 M | - | -4.66 M | -4.64 M | -4.49 M | - | -2.4 M | -2.43 M | -2.98 M | - | -1.6 M | -2.4 M | -1.25 M | - | -1.97 M | -2.25 M | -4.24 M | - | -3.12 M | -3.01 M | -2.41 M | - | -1.3 M | -1.29 M | -677 K | - | -961 K | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
80.2 M | 24.9 M | 23.5 M | - | 10.4 M | 8.62 M | 8.47 M | - | 6.24 M | 6.78 M | 5.77 M | - | 8.29 M | 11.1 M | 9.16 M | - | 7.86 M | 11.2 M | 9.28 M | - | 6.13 M | 5.62 M | 4.98 M | - | 3.88 M | 3.41 M | 3.48 M | - | 2.63 M | 2.97 M | 1.37 M | - | 1.97 M | 2.25 M | 4.25 M | - | 3.37 M | 3.12 M | 2.43 M | - | 1.32 M | 1.31 M | 684 K | - | 993 K | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
49.2 M | 10.9 M | 8.47 M | - | 3.32 M | 3.17 M | 2.85 M | - | 2.33 M | 2.47 M | 2.64 M | - | 2.77 M | 2.46 M | 2.98 M | - | 2.26 M | 2.25 M | 2 M | - | 1.62 M | 1.7 M | 2.01 M | - | 1.56 M | 1.77 M | 1.87 M | - | 1.68 M | 2.2 M | 1.02 M | - | 1.26 M | 1.42 M | 1.94 M | - | 1.71 M | 1.43 M | 1.29 M | - | 522 K | 746 K | 312 K | - | 248 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency